XT
VXRT

XTX Topco’s Vaxart VXRT Stock Holding History

XTX Topco’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-94,258
Closed -$34.4K – 3865
2025
Q3 		$34.4K Buy
94,258
+70,364
+294% +$28.9K ﹤0.01% 2236
2025
Q2 		$10.8K Buy
+23,894
New +$10.4K ﹤0.01% 2227
2025
Q1 		– Sell
-65,177
Closed -$43.2K – 3184
2024
Q4 		$43.2K Sell
65,177
-71,289
-52% -$49.5K ﹤0.01% 1921
2024
Q3 		$116K Buy
136,466
+122,387
+869% +$93.6K 0.01% 1580
2024
Q2 		$9.39K Buy
+14,079
New +$11.7K ﹤0.01% 1693
2024
Q1 		– Sell
-27,439
Closed -$15.7K – 2369
2023
Q4 		$15.7K Buy
27,439
+13,264
+94% +$9.17K ﹤0.01% 1387
2023
Q3 		$10.7K Sell
14,175
-319,654
-96% -$243K ﹤0.01% 1419
2023
Q2 		$244K Buy
+333,829
New +$310K 0.04% 871
2022
Q3 		– Sell
-12,150
Closed -$43K – 1414
2022
Q2 		$43K Buy
+12,150
New +$45.4K 0.02% 756

Other funds holding VXRT

HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
LCM
LVM Capital Management Portage, Michigan $1.19B AUM 41.5% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.11B AUM 27.11% 1-Year Est. Return
OP
ORG Partners Roanoke, Indiana $568M AUM 24.16% 1-Year Est. Return
AIC
Archer Investment Corporation Carmel, Indiana $469M AUM 19.1% 1-Year Est. Return

XTX Topco's VXRT Position: Q4 2025 in Review

XTX Topco sold out of Vaxart (VXRT) in Q4 2025, closing a stake of 94,258 shares — an estimated $34.4K sold.

XTX Topco first reported a position in VXRT in Q2 2022 and held it in 9 quarters. The position peaked at $244K in Q2 2023. 5 funds tracked by Wall St. Rank hold VXRT as of Q4 2025.

  • XTX Topco reported no remaining Vaxart position as of Q4 2025 after selling out during the quarter.
  • XTX Topco sold 94,258 Vaxart shares in Q4 2025, an estimated $34.4K.
  • XTX Topco first reported a position in Vaxart in Q2 2022 and held it in 9 quarters.
  • XTX Topco's Vaxart position peaked at $244K in Q2 2023.
  • 5 funds tracked by Wall St. Rank held Vaxart as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.